CME
Hitting the Benchmarks in mCRC: A Precision Medicine Quality Initiative for the Care Team
0.75 CME/MOC/CC/NCPD/CPE/AAPA/IPCE
Topics — PeerView
Melanoma Oncolytic Immunotherapy: An Evolving Therapeutic Landscape
Maximum of 1.25 AMA PRA Category 1 Credit(s)™.
Project ECHO® Learning Series: Evolving Role of Bispecific Antibodies as Cancer Therapy
These activities will be CME/CPE/CNE-certified.
Project ECHO®: Pulmonary Toxicities with Immune Checkpoint Inhibitors
Content Derived from a CME Certified Webinar in May 2023
Project ECHO®: Dermatologic Toxicities with Immune Checkpoint Inhibitors
Content Derived from a CME Certified Webinar in April 2023
3-Part Aplastic Anemia On-Demand CME Education Series
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Medical Society of Virginia through the joint providership with Carilion Clinic’s CME Program and OncoLens. Carilion Clinic’s CME Program is accredited by The Medical Society of Virginia to provide continuing medical education for physicians. Carilion Clinic’s CME Program designates this enduring material activity for a maximum of 3 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Topics — Carillion Clinic
Project ECHO®: Hepatobiliary Toxicities with Immune Checkpoint Inhibitors
Content Derived from a CME Certified Webinar in March 2023
Project ECHO®: Neurological Toxicities with Immune Checkpoint Inhibitors
Content Derived from a CME Certified Webinar in February 2023
Project ECHO®: Rheumatologic Toxicities with Immune Checkpoint Inhibitors
Content Derived from a CME Certified Webinar in January 2023
Project ECHO®: Endocrine Toxicities with Immune Checkpoint Inhibitors
Content Derived from a CME Certified Webinar in November 2022
Project ECHO®: Gastroenterology Toxicities with Immune Checkpoint Inhibitors
Content Derived from a CME Certified Webinar in October 2022
Project ECHO®: Cardiovascular Toxicities with Immune Checkpoint Inhibitors
Content Derived from a CME Certified Webinar in September 2022
Project ECHO® Learning Series: Telementoring to Manage Immune-Related Adverse Events in Patients Receiving Cancer Immunotherapies
These activities will be CME/CPE/CNE-certified.
Optimizing Frontline Immunotherapy in Advanced Non-Small Cell Lung Cancer
Physician: .75 AMA PRA Category 1 Credit(s)™
Topics — NSCLC
Molecular Testing in the Community Oncology Setting
Content Derived from a CME Certified Webinar in June 2021